Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Infectious Disease
•
Neurology
•
Neuromuscular
Do patients on eculizumab or ravulizumab require repeat vaccination against meningococcal infection after a certain interval?
Answer from: at Academic Institution
Yes, CDC recommends a booster Men B vaccine 1 year after completion of series and then every 2-3 years thereafter, and booster Men C every 5 years.
Sign In
or
Register
to read more
16983
Related Questions
How can I incorporate neuromuscular ultrasound into my practice with limited prior experience?
How do you counsel patients and doctors on antibiotic avoidance in myasthenia gravis?
What are your vaccine recommendations while patients are on biologics?
What work-up and treatment do you recommend for exertional headaches?
When do you consider attributing isolated psychosis to an acute ischemic stroke?
Should asymptomatic esophageal candidiasis identified incidentally on endoscopy be treated?
How do you adjust chronic outpatient steroid therapy when myasthenia gravis patients are admitted for crisis?
What factors do you consider when choosing between baloxavir and oseltamivir for treating patients with influenza?
What is your approach to iron supplementation in patients with an active infection?
How do you approach weaning treatments for CIDP in remission?